HOXA10 and prostate cancer: Hypoxia-inducible miR-1181 is a known tumour suppressor in cancers such as pancreatic, ovarian and prostate cancer and is shown to target SOX2, STAT3 and HOXA10 to inhibit proliferation, migration and invasion and to promote EMT43–47.